Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer (Dec 2017)

p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status (Jun 2017)